The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major

NCT02984475 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Beta Thalassemia Major Anemia

Interventions

DRUG: Metformin

Sponsor

Cairo University